Literature DB >> 25766292

Predicting vaccine responsiveness.

Scott D Boyd1, Katherine J L Jackson2.   

Abstract

Vaccination has saved many lives and prevented needless suffering from disease, but it is not always effective. Immune responses are a highly "personalized" aspect of an individual's biology, as they are subject to germline genetic influences but are embodied in cell populations that continuously sample the environment. Additionally, immunity is shaped by memory of prior infectious diseases and other antigenic exposures. Here, we review examples of recent technical advances and insights into human vaccine responses that are helping to define the features associated with successful vaccination and that may enable a more predictive vaccinology in the future.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25766292     DOI: 10.1016/j.chom.2015.02.015

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  10 in total

Review 1.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

Review 2.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

Review 3.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

4.  Lupus anti-ribosomal P autoantibody proteomes express convergent biclonal signatures.

Authors:  M A Al Kindi; A D Colella; D Beroukas; T K Chataway; T P Gordon
Journal:  Clin Exp Immunol       Date:  2016-01-29       Impact factor: 4.330

5.  Perturbation of B Cell Gene Expression Persists in HIV-Infected Children Despite Effective Antiretroviral Therapy and Predicts H1N1 Response.

Authors:  Nicola Cotugno; Lesley De Armas; Suresh Pallikkuth; Stefano Rinaldi; Biju Issac; Alberto Cagigi; Paolo Rossi; Paolo Palma; Savita Pahwa
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

6.  Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.

Authors:  Yang Li; Ming-Liang Ma; Qing Lei; Feng Wang; Wei Hong; Dan-Yun Lai; Hongyan Hou; Zhao-Wei Xu; Bo Zhang; Hong Chen; Caizheng Yu; Jun-Biao Xue; Yun-Xiao Zheng; Xue-Ning Wang; He-Wei Jiang; Hai-Nan Zhang; Huan Qi; Shu-Juan Guo; Yandi Zhang; Xiaosong Lin; Zongjie Yao; Jiaoxiang Wu; Huiming Sheng; Yanan Zhang; Hongping Wei; Ziyong Sun; Xionglin Fan; Sheng-Ce Tao
Journal:  Cell Rep       Date:  2021-03-12       Impact factor: 9.423

7.  Evaluation of determinants of the serological response to the quadrivalent split-inactivated influenza vaccine.

Authors:  Shaohuan Wu; Ted M Ross; Michael A Carlock; Elodie Ghedin; Hyungwon Choi; Christine Vogel
Journal:  Mol Syst Biol       Date:  2022-05       Impact factor: 13.068

8.  High-throughput sequencing insights into T-cell receptor repertoire diversity in aging.

Authors:  Jörg J Goronzy; Qian Qi; Richard A Olshen; Cornelia M Weyand
Journal:  Genome Med       Date:  2015-11-19       Impact factor: 11.117

9.  Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype.

Authors:  Clare M Smith; Megan K Proulx; Andrew J Olive; Dominick Laddy; Bibhuti B Mishra; Caitlin Moss; Nuria Martinez Gutierrez; Michelle M Bellerose; Palmira Barreira-Silva; Jia Yao Phuah; Richard E Baker; Samuel M Behar; Hardy Kornfeld; Thomas G Evans; Gillian Beamer; Christopher M Sassetti
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

10.  Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses.

Authors:  Nicola Cotugno; Lesley De Armas; Suresh Pallikkuth; Paolo Rossi; Paolo Palma; Savita Pahwa
Journal:  J Virus Erad       Date:  2015-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.